Matthew Perry on 17 February 2015. Photograph: Brian Ach/Invision/APMatthew Perry on 17 February 2015. Photograph: Brian Ach/Invision/APDrug counselor who delivered ketamine dose that killed Matthew Perry gets two yearsErik Fleming was sentenced in Los Angeles court after previously pleading guilty over the Friends actor’s 2023 death
A licensed drug addiction counselor who delivered Friends star Matthew Perry the doses of ketamine that killed him was sentenced on Wednesday to two years in prison.
Judge Sherilyn Peace Garnett handed down the sentence to 56-year-old Erik Fleming in a federal court in Los Angeles.
“It’s truly a nightmare I can’t wake up from,” Fleming told the judge before the sentence. “I’m haunted by the mistakes I made.” He wore a black suit and spoke at the podium with a deep, somber voice.
Fleming was the fourth defendant sentenced of the five who have pleaded guilty in prosecutions over the actor’s 2023 death in the Jacuzzi at his Los Angeles home. Fleming connected Perry to Jasveen Sangha, the convicted drug dealer whom prosecutors called “the Ketamine Queen”. She was sentenced last month to 15 years in prison.
Fleming gave up Sangha to investigators as soon as they contacted him and in August 2024 became the first defendant to plead guilty, admitting to one count of distribution of ketamine resulting in death. That was before arrests in the case were even announced, and Wednesday’s court appearance was his first since his role became public knowledge.
Tributes pour in for ‘comedic genius’ Matthew Perry, dead at 54Read moreHe would have gotten about four years in prison if it weren’t for his cooperation, according to federal sentencing guidelines.
Prosecutors said in a sentencing memo before the hearing that while Fleming’s exceptional cooperation should bring a lighter sentence, his role as a drug counselor who “deliberately undertook to sell illegal street drugs to a victim who had a public, well-documented battle with drug addiction” should count against him, even if Perry wasn’t one of his regular clients.
Defense lawyers had asked for a sentence of three months in prison and nine months in a residential drug treatment facility, saying in their sentencing memo that Fleming “has gone to extreme lengths to atone for his criminal conduct”.
He said his great remorse “can’t compare to the agony I’ve caused” to Perry’s family and friends.
Perry had been receiving ketamine treatments for depression – an increasingly common off-label use.
A few weeks before his death, Perry was seeking more of the drug than he could obtain through doctors and asked a friend to help him get more. She was in a treatment facility, so she introduced Perry to Fleming. He was a former film and television producer whose career had been ravaged by addiction. He got sober and became a drug counselor, but had relapsed after the 2023 death of a beloved stepmother who had rescued him from a traumatic childhood, his lawyers said.
Fleming would get ketamine from Sangha, mark up the price to make a profit and deliver it to Perry’s house, where he sold it to the actor’s live-in personal assistant, Kenneth Iwamasa.
“I procured ketamine for Matthew Perry because I wanted the money and because I thought I was doing a favor for a friend,” Fleming said in a letter to the court. “I never contemplated the worst possible outcome. This grievous failure will haunt me for ever.”
His deliveries included 25 vials for $6,000 four days before Perry’s death.
Iwamasa would inject Perry from that batch on 28 October 2023, and hours later, he found the actor dead. A medical examiner’s report found that Perry died from the acute effects of ketamine, a surgical anesthetic, and drowning was a secondary cause.
Iwamasa is set to be the last defendant sentenced in two weeks.
Perry, who died aged 54, became one of the biggest stars of his generation as Chandler Bing on Friends, NBC’s culture-changing sitcom that ran from 1994 to 2004.
An auction of his valuables including Friends memorabilia will go to benefit the foundation founded in his name after his death.
Explore more on these topicsShareReuse this content
